Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
GlobeNewswire
BLA resubmission anticipated in second half of 2024Closed $75 million underwritten offering in May, extending expected cash runway..
Epidermolysis bullosa
News and Video Search Results
News coverage
-
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
GlobeNewswire
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO
GlobeNewswire
-
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
-
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire
0 shares
1 views
You might like
Epidermolysis bullosa media coverage
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
GlobeNewswire
PITTSBURGH, May 02, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage..
-
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
Business Wire
-
Relief Therapeutics has Published its Annual Report
Accesswire
-
The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
Business Wire
-
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
GlobeNewswire
Advertisement
More coverage
Abeona Therapeutics Provides Regulatory Update on Pz-cel
GlobeNewswire
Receives FDA Complete Response Letter (CRL) based on need for additional CMC informationCRL did not identify deficiencies related..
-
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
GlobeNewswire
-
Japan CL2020 Drug Research Report 2024: A Product Based on Muse Cells Currently Progressing with Clinical Trials for 6 Indications - 7MM Market Size, Forecast, and Emerging Insights 2019-2032
GlobeNewswire
-
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
GlobeNewswire
-
Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards
GlobeNewswire